A pilot study in north London in which a network of GP practices proactively contacted their patients to suggest statins found higher takeup levels. This was one of several studies at BHIVA to find ...

With deep regret the trustees of NAM Publications, publishers of aidsmap.com, decided in July 2024 that the charity was no longer financially sustainable. While honouring their commitment to staff, ...

📢 With heavy hearts, we announce the proposed closure of our beloved charity, NAM aidsmap, this month. After 37 years of pioneering health journalism, community engagement, and empowerment through ...

It’s rare in any branch of medicine that a trial of a new drug can report 100% efficacy, and a first in HIV science. But that’s what happened on Friday, when Gilead Sciences announced that no HIV ...

Research suggests these RT enzymes may be still able to introduce random genetic recombinations and amplifications (increasing the copy number of certain harmful genes) in the brain cells causing them ...

In the same session, Dr Jenell Stewart of the Hennepin Healthcare Research Institute in Minneapolis, US argued that event-driven PrEP is demonstrably as effective as daily PrEP for gay men and trans ...

A programme in rural Kenya and Uganda that has already demonstrated that a dynamic, person-centred HIV prevention intervention results in substantial increases in the numbers of people covered by PrEP ...

The San Francisco Department of Public Health (SF DPH) was ahead of the game, issuing doxyPEP recommendations a year earlier and getting a head start on compiling real-world data. San Francisco’s ...

Gene editing with CRISPR/Cas9 can lead to unwanted ‘cuts’ and changes in the gene sequences near to the integrated HIV genes, Dutch researchers report in the Journal of Virology. This might activate ...

BHIVA recommends that people aged 40 and over should be offered a statin irrespective of lipid levels or estimated cardiovascular risk. People with HIV aged 40 and over with an estimated 10-year risk ...

A more comprehensive picture comes from a French cohort of people living with HIV aged over 70. With around 500 study participants, this may be the largest cohort of people living with HIV over 70 in ...

An HIV vaccine candidate has proved it can guide B-cells, the part of the immune system that makes antibodies, into being able to produce broadly neutralising antibodies (bnAbs) with the ability to ...